Nuvectis Pharma, Inc.

NVCT chart

Nuvectis Pharma, Inc. news

• Weekly Recap: Q3 revenue and loss and FDA consultation on China PNH data

  TradingView · Nov 9, 6:00 AM EST

• Nuvectis Pharma Insiders Enjoying US$141k Appreciation On US$1.17m Investment

  Simply Wall St · Nov 7, 7:23 AM EST

• Nuvectis Pharma, Inc. (NVCT) Seasonal returns chart

  Yahoo Finance UK · Nov 5, 7:05 PM EST

• Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $30

  Moomoo · Nov 5, 5:31 PM EST

• What Could Nuvectis Pharma's(NASDAQ:NVCT) In-Licensing Deal Mean for Its Complement and Oncology Pipeline?

  Kalkine · Nov 4, 8:39 PM EST

• Nuvectis Pharma, Inc. Q3 2026 Earnings Call Summary

  app.moby.co · Nov 4, 6:24 PM EST

• Nuvectis Pharma Inc (NVCT) (Q3 2026) Earnings Call Highlights: Late-Stage Transformation, $140 ...

  Yahoo Finance · Nov 4, 4:06 PM EST

• Nuvectis Pharma Q3 Earnings Call Highlights

  marketbeat.com · Nov 4, 2:14 PM EST

• Nuvectis (NVCT) Q3 2026 Earnings Call Transcript

  fool.com · Nov 4, 12:17 PM EST

• Nuvectis Pharma Inc reports results for the quarter ended September 30 - Earnings Summary

  TradingView · Nov 4, 9:31 AM EST

• Nuvectis Pharma Q3 2026 Earnings Call Transcript

  Benzinga · Nov 4, 8:59 AM EST

• Nuvectis Pharma Q3 2026 Earnings Call Is Live

  TradingView · Nov 4, 7:57 AM EST

Nuvectis Pharma, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-04
• 8-KFORM 8-K2026-11-04
• 8-KFORM 8-K2026-08-21
• 10-Q10-Q2026-08-04
• 8-KFORM 8-K2026-08-04
• 8-KFORM 8-K2026-06-30
• 8-KFORM 8-K2026-06-29
• 8-KFORM 8-K2026-06-23
• 8-KFORM 8-K2026-06-12
• 10-Q10-Q2026-05-05
• 8-KFORM 8-K2026-05-05
• DEF 14ADEF 14A2026-04-27

About Nuvectis Pharma, Inc.

Ticker

NVCT (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Fort Lee, NJ

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1875558

Frequently asked questions